iShares Neuroscience & Healthcare (IBRN) Monthly Backtest Results
Backtest Summary
This table summarises how profitable it would have been to have bought this stock at each monthly entry signal. The compound annual growth rate (CAGR) shows the profitability of the trade on an annualised basis.
| Entry Date | Exit Date | Profit or Loss | CAGR |
|---|---|---|---|
| 01 October 2025 | Trade in progress | 19.93% | |
| 01 August 2024 | 03 March 2025 | -5.65% | -9.49% |
| 01 February 2024 | 01 May 2024 | -6.06% | -22.4% |
| 01 November 2022 | 01 March 2023 | -0.58% | -1.75% |
| Total Return | 7.64% | ||
The monthly data for iShares Neuroscience & Healthcare (exchange: ARCX symbol: IBRN) was last updated 27 Dec 2025 06:20. Data for this ETF is available from 26 Aug 2022 - 26 Dec 2025.
